Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)–Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells

A novel ruthenium(III)–pyrimidine Schiff base was synthesized and characterized using different analytical and spectroscopic techniques. Molecular geometries of the ligand and ruthenium complex were investigated using the DFT-B3LYP level of theory. The quantum global reactivity descriptors were also...

Descripción completa

Detalles Bibliográficos
Autores principales: Noureldeen, Amani F. H., Aziz, Safa W., Shouman, Samia A., Mohamed, Magdy M., Attia, Yasmin M., Ramadan, Ramadan M., Elhady, Mostafa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603487/
https://www.ncbi.nlm.nih.gov/pubmed/36294202
http://dx.doi.org/10.3390/ijerph192013624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603487/
https://www.ncbi.nlm.nih.gov/pubmed/36294202
http://dx.doi.org/10.3390/ijerph192013624

Ejemplares similares